RX Pharmatech

Bradford, United Kingdom Founded: 2016 • Age: 10 yrs Acquired By 22nd Century
Cannabis-based products are cultivated and produced by RX Pharmatech.

About RX Pharmatech

RX Pharmatech is a Healthcare company based in Bradford (United Kingdom) founded in 2016, and was acquired by 22nd Century in January 2023. Cannabis-based products are cultivated and produced by RX Pharmatech. Its chief executive, as recorded, is James A Mish. The company was acqui-hired. Its focus areas include HealthTech, Cannabis HealthTech, Cannabis Farming and Indoor Farming.

Company details

RX Pharmatech was founded in 2016 and is based in Bradford, United Kingdom. Operations focus on the cultivation and production of cannabis-derived items within the pharmaceutical sector. Products offered include CBD isolate as well as various finished formulations such as gummies, oils, drops, candies, tinctures, sprays, and capsules. These activities support distribution to relevant markets.

  • Headquarters Bradford, United Kingdom
  • Stage Acquired
  • Sectors
    Healthcare
  • Acquired by 22nd Century (Jan 2023)
Key Metrics

Investors in RX Pharmatech

RX Pharmatech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include 22nd Century.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Manufacturer of nicotine products
1998xxiicentury.comWilliamsville, United States
Premium access

Investor details for RX Pharmatech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of RX Pharmatech

1 people are tracked at RX Pharmatech (1 in leadership).

NameRoleGroup
James A Mish
CEOLeadership
Premium access

Complete people profiles for RX Pharmatech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of RX Pharmatech

2 dated milestones of RX Pharmatech across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded RX Pharmatech is founded.
  2. Exit Acquired by 22nd Century.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about RX Pharmatech

RX Pharmatech was founded in 2016.

RX Pharmatech is headquartered in Bradford, United Kingdom. It is registered at Bradford, West Yorkshire, United Kingdom.

James A Mish is the CEO of RX Pharmatech, as recorded in our data.

RX Pharmatech was founded in 2016 and is based in Bradford, United Kingdom. Operations focus on the cultivation and production of cannabis-derived items within the pharmaceutical sector. Products offered include CBD isolate as well as various finished formulations such as gummies, oils, drops, candies, tinctures, sprays, and capsules. These activities support distribution to relevant markets.

RX Pharmatech has 1 investor. Key investors include 22nd Century.

Yes. RX Pharmatech was acquired by 22nd Century in January 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available